259 related articles for article (PubMed ID: 14701864)
41. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor.
Deepa SS; Yamada S; Zako M; Goldberger O; Sugahara K
J Biol Chem; 2004 Sep; 279(36):37368-76. PubMed ID: 15226297
[TBL] [Abstract][Full Text] [Related]
42. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
Tortorella MD; Pratta MA; Fox JW; Arner EC
J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
[TBL] [Abstract][Full Text] [Related]
43. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells.
Kishibe J; Yamada S; Okada Y; Sato J; Ito A; Miyazaki K; Sugahara K
J Biol Chem; 2000 May; 275(20):15321-9. PubMed ID: 10809767
[TBL] [Abstract][Full Text] [Related]
44. ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan.
East CJ; Stanton H; Golub SB; Rogerson FM; Fosang AJ
J Biol Chem; 2007 Mar; 282(12):8632-40. PubMed ID: 17255106
[TBL] [Abstract][Full Text] [Related]
45. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.
Zeng W; Corcoran C; Collins-Racie LA; Lavallie ER; Morris EA; Flannery CR
Biochim Biophys Acta; 2006 Mar; 1760(3):517-24. PubMed ID: 16507336
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
Steinfeld R; Van Den Berghe H; David G
J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172
[TBL] [Abstract][Full Text] [Related]
47. Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.
Rodríguez-Manzaneque JC; Carpizo D; Plaza-Calonge Mdel C; Torres-Collado AX; Thai SN; Simons M; Horowitz A; Iruela-Arispe ML
Int J Biochem Cell Biol; 2009 Apr; 41(4):800-10. PubMed ID: 18775505
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).
Hashimoto G; Aoki T; Nakamura H; Tanzawa K; Okada Y
FEBS Lett; 2001 Apr; 494(3):192-5. PubMed ID: 11311239
[TBL] [Abstract][Full Text] [Related]
49. ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan.
Hashimoto G; Shimoda M; Okada Y
J Biol Chem; 2004 Jul; 279(31):32483-91. PubMed ID: 15161923
[TBL] [Abstract][Full Text] [Related]
50. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
51. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
Roughley PJ; Barnett J; Zuo F; Mort JS
Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
[TBL] [Abstract][Full Text] [Related]
52. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
53. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
Viklund L; Loo BM; Hermonen J; El-Darwish K; Jalkanen M; Salmivirta M
Biochem Biophys Res Commun; 2002 Jan; 290(1):146-52. PubMed ID: 11779146
[TBL] [Abstract][Full Text] [Related]
54. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
[TBL] [Abstract][Full Text] [Related]
55. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
56. Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content.
Mertens G; Van der Schueren B; van den Berghe H; David G
J Cell Biol; 1996 Feb; 132(3):487-97. PubMed ID: 8636224
[TBL] [Abstract][Full Text] [Related]
57. Modulated glycosylation of proteoglycans during differentiation of human B lymphocytes.
Engelmann S; Ebeling O; Schwartz-Albiez R
Biochim Biophys Acta; 1995 May; 1267(1):6-14. PubMed ID: 7779869
[TBL] [Abstract][Full Text] [Related]
58. Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface.
Yang Y; Børset M; Langford JK; Sanderson RD
J Biol Chem; 2003 Apr; 278(15):12888-93. PubMed ID: 12566461
[TBL] [Abstract][Full Text] [Related]
59. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
60. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.
Bernfield M; Sanderson RD
Philos Trans R Soc Lond B Biol Sci; 1990 Mar; 327(1239):171-86. PubMed ID: 1969657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
